BACKGROUND: Treatment of recent tuberculosis infection in children aged <2 years is essential, because of high risk of progression to disease, but diagnosis is hindered by the inaccuracy of the tuberculin skin test (TST). More-accurate T cell-based tests of infection could enhance diagnosis by optimizing interpretation of the TST results. METHODS: A total of 979 child tuberculosis contacts in Istanbul underwent the TST and enzyme-linked immunospot assay. Using enzyme-linked immunospot test results as a reference standard, we assessed the effect of age and bacille Calmette-Guérin (BCG) vaccination on the sensitivity and specificity of the TST, and we computed the optimal TST cutoff points, using receiver operating characteristic curves. RESULTS: With a TST cutoff point of >or=10 mm, the sensitivity of the TST was 66% for children aged <2 years, which was lower than that for older children (P= .006). Specificity was 75% for BCG-vaccinated children, compared with 92% for unvaccinated children (P= .001). Optimal cutoff points improved TST specificity for children with 1 BCG scar, with little loss of sensitivity. Despite the use of optimal cutoff points, TST sensitivity remained <70% for children aged <2 years, specificity remained <87% for BCG-vaccinated children aged >or=2 years, and overall accuracy was low for children with >1 BCG scar. CONCLUSIONS: Negative results of the TST cannot exclude tuberculosis infection for child tuberculosis contacts aged <2 years, which supports the use of preventive therapy regardless of the TST results for this age group. In children aged >or=2 years, the accuracy of the TST can be improved by adjustment of cutoff points for BCG-vaccinated children but remains poor for children with >1 BCG scar. This methodology can define optimal TST cutoff points for diagnosis of tuberculosis infection tailored to target populations.
BACKGROUND: Treatment of recent tuberculosis infection in children aged <2 years is essential, because of high risk of progression to disease, but diagnosis is hindered by the inaccuracy of the tuberculin skin test (TST). More-accurate T cell-based tests of infection could enhance diagnosis by optimizing interpretation of the TST results. METHODS: A total of 979 child tuberculosis contacts in Istanbul underwent the TST and enzyme-linked immunospot assay. Using enzyme-linked immunospot test results as a reference standard, we assessed the effect of age and bacille Calmette-Guérin (BCG) vaccination on the sensitivity and specificity of the TST, and we computed the optimal TST cutoff points, using receiver operating characteristic curves. RESULTS: With a TST cutoff point of >or=10 mm, the sensitivity of the TST was 66% for children aged <2 years, which was lower than that for older children (P= .006). Specificity was 75% for BCG-vaccinated children, compared with 92% for unvaccinated children (P= .001). Optimal cutoff points improved TST specificity for children with 1 BCG scar, with little loss of sensitivity. Despite the use of optimal cutoff points, TST sensitivity remained <70% for children aged <2 years, specificity remained <87% for BCG-vaccinated children aged >or=2 years, and overall accuracy was low for children with >1 BCG scar. CONCLUSIONS: Negative results of the TST cannot exclude tuberculosis infection for child tuberculosis contacts aged <2 years, which supports the use of preventive therapy regardless of the TST results for this age group. In children aged >or=2 years, the accuracy of the TST can be improved by adjustment of cutoff points for BCG-vaccinated children but remains poor for children with >1 BCG scar. This methodology can define optimal TST cutoff points for diagnosis of tuberculosis infection tailored to target populations.
Authors: Philip C Hill; Roger H Brookes; Ifedayo M O Adetifa; Annette Fox; Dolly Jackson-Sillah; Moses D Lugos; Simon A Donkor; Roger J Marshall; Stephen R C Howie; Tumani Corrah; David J Jeffries; Richard A Adegbola; Keith P W J McAdam Journal: Pediatrics Date: 2006-05 Impact factor: 7.124
Authors: Luca Richeldi; Katie Ewer; Monica Losi; Barbara M Bergamini; Pietro Roversi; Jonathan Deeks; Leonardo M Fabbri; Ajit Lalvani Journal: Am J Respir Crit Care Med Date: 2004-05-06 Impact factor: 21.405
Authors: Ann L N Chapman; Mwansa Munkanta; Katalin A Wilkinson; Ansar A Pathan; Katie Ewer; Helen Ayles; William H Reece; Alwyn Mwinga; Peter Godfrey-Faussett; Ajit Lalvani Journal: AIDS Date: 2002-11-22 Impact factor: 4.177
Authors: Victoria O Kasprowicz; Gavin Churchyard; Stephen D Lawn; S Bertel Squire; Ajit Lalvani Journal: J Infect Dis Date: 2011-11-15 Impact factor: 5.226
Authors: Roi Piñeiro; María José Mellado; María José Cilleruelo; Marta García-Ascaso; Antonio Medina-Claros; Milagros García-Hortelano Journal: Eur J Pediatr Date: 2012-07-01 Impact factor: 3.183
Authors: Peter J Dodd; Kerry A Millington; Azra C Ghani; Junior Mutsvangwa; Anthony E Butterworth; Ajit Lalvani; Elizabeth L Corbett Journal: Am J Epidemiol Date: 2010-04-09 Impact factor: 4.897
Authors: Manish Pareek; John P Watson; L Peter Ormerod; Onn Min Kon; Gerrit Woltmann; Peter J White; Ibrahim Abubakar; Ajit Lalvani Journal: Lancet Infect Dis Date: 2011-04-20 Impact factor: 25.071
Authors: Davinder P S Dosanjh; Mustafa Bakir; Kerry A Millington; Ahmet Soysal; Yasemin Aslan; Serpil Efee; Jonathan J Deeks; Ajit Lalvani Journal: PLoS One Date: 2011-12-28 Impact factor: 3.240
Authors: Maunank Shah; Tafadzwa S Kasambira; Peter V Adrian; Shabir A Madhi; Neil A Martinson; Susan E Dorman Journal: PLoS One Date: 2011-10-31 Impact factor: 3.240